Which hemoglobin (Hb) patterns on hemoglobin electrophoresis will have a positive sickle solubility (dithionite) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemoglobin Patterns with Positive Sickle Solubility Test

Both hemoglobin patterns AS and SS (option E) will have a positive sickle solubility (dithionite) test because both contain hemoglobin S, which is detected by this test regardless of whether it's present in heterozygous or homozygous form.

Understanding the Sickle Solubility Test

The sickle solubility (dithionite) test is designed to detect the presence of hemoglobin S (HbS) in blood samples. This test works based on the following principles:

  • It detects the presence of HbS by causing insoluble polymers to form when HbS is deoxygenated
  • The test is positive whenever HbS is present, regardless of the amount
  • It cannot differentiate between heterozygous (AS) and homozygous (SS) states 1

Analysis of Hemoglobin Patterns

Let's analyze each hemoglobin pattern in the question:

Positive Sickle Solubility Test:

  • AS (Sickle Cell Trait): Contains 55-65% HbA and 30-40% HbS 2. The presence of HbS, even in heterozygous form, will produce a positive solubility test.
  • SS (Sickle Cell Disease): Contains 80-95% HbS 1. The high concentration of HbS will definitely produce a positive solubility test.

Negative Sickle Solubility Test:

  • AA (Normal): Contains 95-98% HbA with no HbS 1. Without HbS, the solubility test will be negative.
  • AC: Contains HbA and HbC, but no HbS. The solubility test specifically detects HbS, not other hemoglobin variants like HbC.

Clinical Implications

The sickle solubility test has important limitations that clinicians should be aware of:

  • It should not be used in isolation for diagnosis as it cannot differentiate between sickle cell trait (AS) and sickle cell disease (SS) 1
  • False negative results can occur in:
    • Neonates (due to high HbF levels)
    • Heavily transfused patients (dilution of HbS)
  • False positive results are rare but can occur in conditions like polycythemia 3

Diagnostic Algorithm

For proper hemoglobinopathy diagnosis:

  1. Initial screening: Sickle solubility test to detect presence of HbS
  2. Confirmation: If positive, proceed to definitive testing:
    • Hemoglobin electrophoresis
    • High-performance liquid chromatography (HPLC)
    • Capillary electrophoresis
    • Mass spectrometry

These confirmatory tests can differentiate between heterozygous (AS) and homozygous (SS) states, as well as identify other hemoglobin variants that may be present 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sickle Cell Trait Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of SICKLEQUIK, a differential solubility test for hemoglobin S.

The American journal of medical technology, 1979

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.